Drug Type Live attenuated vaccine, Prophylactic vaccine |
Synonyms Skyzoster, NBP 608, NBP-608 + [1] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date KR (29 Sep 2017), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Herpes Zoster | KR | 29 Sep 2017 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chickenpox | Phase 3 | PH | 14 Jul 2016 | |
Vaccination | Phase 1 | KR | 01 Nov 2012 |
Not Applicable | - | HZ vaccine | jnrfniocqc(ftteqlaycn) = qztydrzmls faqyuvrajr (xyzqwfembr ) | Positive | 01 Jun 2018 | ||
No HZ vaccine | jnrfniocqc(ftteqlaycn) = ecihpnxdyr faqyuvrajr (xyzqwfembr ) | ||||||
Phase 3 | - | - | yakgvhkruq(ibjuxsbksl) = Solicited reports of injection-site and systemic reactions within 7 days after injection were more frequent among HZ/su recipients than among placebo recipients wlvfvsrdgy (gqjyuclbqe ) View more | Positive | 15 Sep 2016 | ||
Placebo |